Trial intelligence / Profile preview

EMG Visibility on Anaesthesia Monitor with Rocuronium

NCT01142635Phase 4Completed

Sponsor
Tampere University Hospital
Start
Apr 2009
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of rocuronium in Anesthesia (2 arms), sponsored by Tampere University Hospital. Primary endpoint: The behaviour of biosignal on the anaesthesia monitor at 30 minutes. Started Apr 2009; status: completed.

02

Drugs

rocuronium
03

Conditions

Anesthesia

Beyond the preview

Go deeper on NCT01142635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01142635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call